Study on the Influence of Humanized Nursing Model on the Effect of Intravenous Infusion Care
NCT ID: NCT06569914
Last Updated: 2025-02-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
40 participants
INTERVENTIONAL
2024-09-01
2024-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Study on the Attitude and Empathy of Nursing Students Towards the Elderly
NCT04921423
Digital Learning on Competence in Motivational Interviewing
NCT06003803
The Development of Patient Experience With Nursing Care Scale
NCT04999033
The Effectiveness of Blended and Problem-based Learning to Improve the Competence of Geriatric Nursing Students
NCT05290909
Self-Directed Versus Traditional Clinical Learning Model on Nurses' Airway Management Competencies
NCT04244565
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Control group: Routine nursing, strict implementation of the "three checks and eight pairs" process, strict inspection of the quality of drugs used by patients, and strict adherence to medical advice on drug dosage.
Observation group: Humanized nursing includes humanized environmental care, humanized medical guidance, humanized psychological care, and humanized standardized management of IVGTT treatment process. The specific content is: (1) Humanized environmental care: Increase the frequency of cleaning the ward. If there is vomit or stagnant water, it should be removed as soon as possible to ensure that the ward floor is always kept clean and tidy, and to avoid patients falling due to water stains or foreign objects on the floor. Reasonably increase the number of garbage bins in the ward area. If conditions permit, place magazines, educational manuals, and other items in the ward that can help patients pass the time during the infusion process. (2) Humanized medical guidance: In addition to inquiring about the patient's allergy history and explaining the effects of medication before infusion, explain possible adverse reactions and corresponding treatment measures to the patient to avoid confusion, negative emotions or psychology after adverse reactions occur. If the patient does not have good vascular conditions, nursing staff can help massage the venous area before puncture, if the condition allows. Inform patients to pay attention to any adverse events (such as slipping of infusion set, redness and swelling of puncture site, etc.) during infusion, and immediately notify nursing staff if any are found. (3) Humanized psychological nursing: Many patients resist venipuncture, and nursing staff need to provide health education before IVGTT, so that patients understand the necessity and safety of IVGTT, improve patient cooperation, actively communicate with patients, understand their concerns about IVGTT, and provide timely and correct guidance; Remind family members to care for and encourage patients, so that they can actively cooperate with IVGTT. (4) Humanized and standardized management of IVGTT treatment process: One of the core tasks of nursing work is IVGTT. We strictly follow the hospital's nursing system for IVGTT treatment, strengthen training for nursing staff in terms of service attitude, social skills, puncture skills, etc., comprehensively improve the personal comprehensive literacy of nursing staff, and ensure that all nursing staff can perform venous puncture in a standardized and efficient manner.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
control group
Routine nursing:strict implementation of the "three checks and eight pairs" process, strict inspection of the quality of drugs used by patients, and strict adherence to medical advice on drug dosage.
No interventions assigned to this group
observation group
humanistic nursing:(1) Humanized environmental care;(2) Humanized medical guidance;(3)Humanized psychological nursing;(4) Humanized and standardized management of IVGTT treatment process
Humanized care
(1) Humanized environmental care;(2) Humanized medical guidance;(3)Humanized psychological nursing;(4) Humanized and standardized management of IVGTT treatment process
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Humanized care
(1) Humanized environmental care;(2) Humanized medical guidance;(3)Humanized psychological nursing;(4) Humanized and standardized management of IVGTT treatment process
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Have complete clinical data
* Know and sign the informed consent form
Exclusion Criteria
* Patients with consciousness and cognitive impairments
* Patients with mental illness
18 Years
100 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
The Fourth Affiliated Hospital of Zhejiang University School of Medicine
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
the Fourth Affiliated Hospital of School of Medicine, and International School of Medicine, International Institutes of Medicine
Yiwu, ZhengJiang, China
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
KY-2024-141
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.